Skip to Main Content

Author Details

Laurence Van Overtvelt
Universite Libre de Bruxelles
1999
30
23
PMIDPaper TitleJournal TitlePublished Year
21961022Lactococcus lactis NCC 2287 alleviates food allergic manifestations in sensitized mice by reducing IL-13 expression specifically in the ileum.Clin Dev Immunol2012
22205338Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy.Int Arch Allergy Immunol2012
21105918Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses.Clin Exp Allergy2011
21775981Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice.Mucosal Immunol2011
21883279Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.Allergy2011
21562971Induction of allergen-specific tolerance via mucosal routes.Curr Top Microbiol Immunol2011
21368225Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae.J Immunol2011
21418343Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cells.Clin Exp Allergy2011
20407270Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.Int Arch Allergy Immunol2010
20175969Lactic acid bacteria as adjuvants for sublingual allergy vaccines.Vaccine2010
19220212Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.Allergy2009
19694757Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.Clin Exp Allergy2009
19647862Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.J Allergy Clin Immunol2009
19183416Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation.Allergy2009
19265114Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.J Immunol2009
19226276Production of native and modified recombinant Der p 1 molecules in tobacco plants.Clin Exp Allergy2009
17848808IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.Int Arch Allergy Immunol2008
18774396Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.J Allergy Clin Immunol2008
18644025Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.Clin Exp Allergy2008
18660382Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".Blood2008
18204276Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects.Int Arch Allergy Immunol2008
18354173Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers.J Immunol2008
17207260Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens.Plant Biotechnol J2007
18063445A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.Vaccine2007
17531296Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.J Allergy Clin Immunol2007
16701145Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.Immunol Allergy Clin North Am2006
17124785Sublingual vaccines based on wild-type recombinant allergens.Eur Ann Allergy Clin Immunol2006
16409190Immune mechanisms of allergen-specific sublingual immunotherapy.Allergy2006
12356679Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes.Int Immunol2002
10417171Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules.Infect Immun1999
  • 1 - 30 of 30

Recommended Authors

University of Virginia
Career Start Year 2016
Number of shared co-authors 1
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year 2011
Number of shared co-authors 0
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 1
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich
Career Start Year 2008
Number of shared co-authors 0
University of California san francisco
Career Start Year 2006
Number of shared co-authors 2
Genentech Inc.
Career Start Year 2005
Number of shared co-authors 0
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 2004
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2003
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 1999
Number of shared co-authors 0
Columbia University
Career Start Year 1999
Number of shared co-authors 1
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 0
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1995
Number of shared co-authors 1
University of Perugia
Career Start Year 1995
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 1994
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1992
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1992
Number of shared co-authors 1
National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1989
Number of shared co-authors 0
University of Cape Town
Career Start Year 1989
Number of shared co-authors 0
University of Perugia
Career Start Year 1988
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1986
Number of shared co-authors 0
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1984
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
University of Virginia
Career Start Year 1974
Number of shared co-authors 1
A. Menarini Biomarkers Singapore Pte Ltd
Career Start Year 1973
Number of shared co-authors 0

Collaborators

France French Academy of Pharmacy
Co-authored papers 28
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 7
University of Colorado - Anschutz Medical Campus
Co-authored papers 1
EpiVax Inc.
Co-authored papers 1
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 1
University of Arizona
Co-authored papers 1
University of Georgia
Co-authored papers 1
EpiVax Inc.
Co-authored papers 1
University of British Columbia
Co-authored papers 1